| Company Name: | Celera Corporation | | Ticker Symbol: | CRA | | | WWW Address: | www.celera.com | | CEO: | Kathy P. Ordonez | | No. of Employees: | 554 | | Common Issue Type: | CS | | Business Description: | The company is in the diagnostics business and delivers disease management through a clinical laboratory testing service business, a products business and a segment which includes other activities under corporate management.
|
| | | Industry Information: | ELECTRONICS - Scientific & Technical Instruments [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 6.2 |  -0.09 | 5.64 | 6.41 | 6.29 | 6.35 | 6.20 | 359420 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 508.1 | 81.9 | 1.13 | -1.31 | 0.00 | 0.0 | 0.0 | 11.71 - 5.03 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 6.20 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 508.1 | mil |
| Latest Shares Outstanding | 81.9 | mil |
| Earnings pS (EPS) | -1.31 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 250,303 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 80.4 | mil |
| Float as % of Shares Outstanding | 98.3 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 0.0 | % |
| EBITDA Margin | 0.0 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 0.0 | % |
| Return on Assets (ROA) | 0.0 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | 0.0 | % |
| Current Ratio | 11.6 | |
| Leverage Ratio (Assets/Equity) | 1.1 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 4.16 | $ |
| Cash pS | 0.90 | $ |
| Book-Value pS | 7.18 | $ |
| Tangible Book-Value pS | 4.49 | $ |
| Cash Flow pS | -1.17 | $ |
| Free Cash Flow pS | -0.22 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.86 | |
| Price/Tangible Book Ratio | 1.38 | |
| Price/Cash Flow | -5.3 | |
| Price/Free Cash Flow | -27.6 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -0.8 | 98 | 3,729 | 6,178 |
| 4 Weeks | 6.62 | 6.07 | 6.19 | 0.2 | 94 | 4,271 | 72,601 |
| 13 Weeks | 6.70 | 5.97 | 6.55 | -5.3 | 88 | 6,953 | 424,126 |
| 26 Weeks | 8.76 | 5.27 | 7.57 | -18.1 | 68 | 7,921 | 990,067 |
| 52 Weeks | 11.71 | 5.03 | 9.74 | -36.3 | 52 | 7,115 | 1,771,631 |
| YTD | 11.71 | 5.03 | - | -44.3 | 45 | 7,282 | 1,653,116 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 6.30 | 6.34 | 6.30 | 6.87 | 6.97 | 1.13 | 1.03 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 4.91 | 2.8 | 55.68 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -7.02 | NA | 157.53 |
| R&D | -19.59 | NA | -28.75 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 219.7 | 320.4 | 219.7 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | -1.06 | -1.13 | -1.06 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 57.02 |
| Current Ratio | 13.7 |
| Quick Ratio (Acid Test) | 12.3 |
| Liquidity Ratio (Cash) | 11.01 |
| Receivables Turnover | 6.1 |
| Average Collection Period | 59 |
| Working Capital/Equity | 61.7 |
| Working Capital pS | 4.81 |
| Cash-Flow pS | -1.13 |
| Free Cash-Flow pS | -2.81 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 6.50 |
| Financial Leverage Ratio (Assets/Equity) | 1.1 |
| Debt Ratio | 7.6 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 3.4 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.52 |
| Tobin's Q Ratio | 0.75 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | -12.77 |
| Enterprise Value (EV)/Free Cash Flow | -1.38 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 1.38 |
| Price/Book Ratio - LTM | 0.86 |
| Price/Cash Flow Ratio | -5.3 |
| Price/Free Cash Flow Ratio - LTM | -27.6 |
| Price/Sales Ratio | 2.90 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.38 |
| Tangible Book Value pS - LTM | 4.49 |
| Book Value pS - LTM | 7.18 |
| Capital Invested pS | 7.64 |
| Cash pS - LTM | 0.90 |
| Cash Flow pS - LTM | -1.17 |
| Free Cash Flow pS - LTM | -0.22 |
| Earnings pS (EPS) | -1.31 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -162.90 |
| Free Cash Flow Margin 5YEAR AVG | -184.62 |
| Net Profit Margin | -75.0 |
| Net Profit Margin - 5YEAR AVRG. | 0.0 |
| Equity Productivity | 0.22 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 0.22 |
| Return on Capital Invested (ROCI) | -16.6 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -8.4 |
| Assets Productivity | 0.20 |
| Return on Assets (ROA) | -15.4 |
| Return on Assets (ROA) - 5YEAR AVRG. | -7.8 |
| Gross Profit Margin | 0.0 |
| Gross Profit Margin - 5YEAR AVRG. | 87.2 |
| EBITDA Margin - LTM | 0.0 |
| EBIT Margin - LTM | 0.0 |
| Pre-Tax Profit Margin | -10.8 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 0.0 |
| Effective Tax Rate | -596.5 |
| Effective Tax Rate - 5YEAR AVRG. | -85.6 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 199 |
| Revenue per Employee | 250,303 |
| Net Income per Employee | -187,841 |
| Average Collection Period | 102 |
| Receivables Turnover | 6.1 |
| Day's Inventory Turnover Ratio | 97 |
| Inventory Turnover | 3.7 |
| Inventory/Sales | 6.7 |
| Accounts Payble/Sales | 4.39 |
| Assets/Revenue | 5.00 |
| Net Working Capital Turnover | 0.36 |
| Fixed Assets Turnover | 0.53 |
| Total Assets Turnover | 0.2 |
| Revenue per $ Cash | 2.93 |
| Revenue per $ Plant | 12.63 |
| Revenue per $ Common Equity | 0.22 |
| Revenue per $ Capital Invested | 0.22 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 58.9 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 63.5 |
| Research & Devlopment (R&D) as % of Revenue | 29.5 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 29.5 |
|
|  
|
| |
 |  |